IMPAX, Actavis Wellbutrin generics approved
HAYWARD, Calif. The Food and Drug Administration has approved IMPAX Laboratories' generic version of GlaxoSmithKline's antidepressant Wellbutrin, IMPAX said in a statement Monday.
It also approved Icelandic generic drug maker Actavis' version, Actavis said Monday.
IMPAX is selling the drug, known generically as bupropion hydrochloride, in a 150 mg, extended-release formulation.
Wellbutrin XL 150 mg had sales of $1.48 billion in the 12 months ending in September, according to IMS Health data.